(9beta,10alpha)-Pregn-4-ene-3,20-dione

HCID 92940

Basic information

CAS
2755-10-4
Standard SMILES
CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
InChIKey
RJKFOVLPORLFTN-HQZYFCCVSA-N
Molecular formula
C21H30O2
Average molar mass
314.5 g/mol
Monoisotopic mass
314.2245802

Names & identifiers

Preferred name
(9beta,10alpha)-Pregn-4-ene-3,20-dione
IUPAC
(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
English name
9beta,10alpha-pregn-4-ene-3,20-dione
Molecular formula
C21H30O2
Molecular weight
314.4617

Names & synonyms

Retroprogesterone2755-10-4R94ZS616JR(9beta,10alpha)-pregn-4-ene-3,20-dioneDTXSID101335986RefChem:1050751DTXCID301766058220-407-9Lumiprogesterone9beta,10alpha-Pregn-4-ene-3,20-dione(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-oneUNII-R94ZS616JR
Show more names
(9β,10α)-Progesterone(9β,10α)-Pregn-4-ene-3,20-dionePregn-4-ene-3,20-dione, (9β,10α)-(9β,10α)-pregna-4-en-3,20-one/Retroprogesterone(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
9.beta.,10.alpha.-ProgesteroneEINECS 220-407-99.beta.,10.alpha.-Pregn-4-ene-3,20-dionePregn-4-ene-3,20-dione, (9.beta.,10.alpha.)-Pregn-4-ene-3,20-dione #orb1985362SCHEMBL3931579AKOS040753738

Database identifiers

CAS
2755-10-4
PubChem CID
92940
DTXSID
DTXSID101335986
UNII
R94ZS616JR
EC Number
220-407-9
Nikkaji
J121.798D

Properties

Computed structural properties

XLogP
3.9
Topological polar surface area
34.1 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
1
Heavy atoms
23

Experimental & physicochemical properties

Endocrine DisruptorsPotential endocrine disrupting compound

Physicochemical properties

Melting point
154 · 154-156 °C
Boiling point
447.2 · 447.2±45.0 °C(Predicted)
Density
1.08 · 1.08±0.1 g/cm3(Predicted)
FDA UNII
94 ZS616JR · R94ZS616JR

Chemistry & industry

Applications

UsesRetroprogesterone is employed as a combine menopause hormonal therapy, to ameliorate the risk of breast cancer in postmenopausal women.

Suppliers5 total

湖北瑞玛标物科技有限公司15787879035 15787875101 · [email protected]
常州非凡医药科技有限公司0519-82111935 15195055733 · [email protected]
上海佰世凯生物科技有限公司021-20908456 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
山东子易医药有限公司13173053288 · [email protected]

Related reactions

0 records

No reaction records under the current filter.

Compound notes

Loading…